GREM1 and breast cancer: Given that loss of stromal BMPR2 expression increases cytokine production in a mouse model of breast cancer,28 further studies are warranted to investigate whether mesenchymal BMP signaling, modulated by GREM1 and ISLR, could also be involved in shaping the immunosuppressive tumor microenvironment.